Stock Updates

Is this Large Market Cap Stock target price reasonable for Bristol-Myers Squibb Company (NYSE:BMY)?

The company in question is, Bristol-Myers Squibb Company (NYSE:BMY) currently with a stock price of 55.08 (-0.94% today). The market cap for Bristol-Myers Squibb Company is 92643.46, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Bristol-Myers Squibb Company is 68.35. Currently Bristol-Myers Squibb Company is trading with a P/E of 32.23, and a forward P/E of 18.38. Average volume for Bristol-Myers Squibb Company is 10932.95 and so far today it is 10508900.

Performance in the last year for Bristol-Myers Squibb Company has been -12.40%. For EPS growth, Bristol-Myers Squibb Company has seen a growth of -22.30%, and is looking to grow in the next year to 14.04%. More long term stats show that EPS growth has been -12.20% over the last five years and could be 19.59% for the next five years. Bristol-Myers Squibb Company has seen sales growth quarter over quarter at 17.00%, with EPS growth quarter over quarter at 990.60%. The 20-day simple moving average is -15.57%, with the 200-day simple moving average coming to -17.07%.

Since the IPO date for Bristol-Myers Squibb Company on the 6/1/1972, Bristol-Myers Squibb Company has seen performance year to date to be -19.03%. With Bristol-Myers Squibb Company trading at 55.08, the dividend yield is 2.76%, and the EPS is 1.71.

So could Bristol-Myers Squibb Company, be undervalued? Well as said before P/E is 32.23. The PEG is 1.65, P/S is 5.26 and the P/B is at 6.17. The P/cash is 19.92, with P/free cash flow at *TBA.

Bristol-Myers Squibb Company ability to deal with debt shows that the current ratio is 1.6, and the quick ratio is 1.4. This is with long term debt/equity at 0.44, and total debt/equity at 0.45.

In terms of margins, Bristol-Myers Squibb Company has a gross margin of 75.70%, an operating margin of 20.80% and a profit margin of 16.30%.Payout ratio for Bristol-Myers Squibb Company is 87.80%. Return on assets come to 9.00% with return on investment coming to 4.60%.

Insider ownership for Bristol-Myers Squibb Company, is at 0.10% and institutional ownership comes to 74.30%. Outstanding shares are at 1681.98. While shares float is 1504.56. The float short is currently 0.82%, and short ratio is 1.13.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment